Company Filing History:
1 out of 1,012 
1 out of 449 
1 out of 832,912 Years Active: 2008
Title: Martin Månsson: Innovator in Lipopolysaccharide Research
Introduction
Martin Månsson is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of immunology, particularly in the development of vaccines targeting bacterial infections. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Martin Månsson holds a patent related to a lipopolysaccharide moiety. This invention comprises a conserved triheptosyl inner-core moiety of lipopolysaccharide that is substantially free of variable outer core oligosaccharide chain extension. The patent also discusses vaccines derived from this moiety, which are cross-reactive for various strains. Additionally, it addresses defined mutations in the biosynthetic machinery for lipopolysaccharide expression, which are useful for obtaining the aforementioned moiety. The invention further explores the use of conjugates of the lipopolysaccharide from mutant strains to elicit a heterologous immune response against a wide range of disease-causing strains. Specifically, it relates to vaccines for the prevention of bacterial infections comprising core lipopolysaccharide.
Career Highlights
Throughout his career, Martin Månsson has worked with esteemed organizations, including the National Research Council of Canada and Oxford University Innovation Limited. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Martin has collaborated with notable colleagues such as James C. Richards and Andrew Cox. These partnerships have enriched his research and expanded the impact of his innovations in the scientific community.
Conclusion
Martin Månsson is a distinguished inventor whose work in lipopolysaccharide research has the potential to significantly advance vaccine development. His contributions reflect a commitment to improving public health through innovative solutions.